Burcon Rights to Commence Trading on February 14, 2014
February 07 2014 - 6:36PM
Burcon NutraScience Corporation (TSX:BU)
(Nasdaq:BUR) ("
Burcon") announced earlier today
that it will be offering rights (the "
Rights") to
holders of its common shares of record at the close of business on
February 19, 2014. Please be advised that the Rights will commence
trading on the Toronto Stock Exchange ("
TSX") on
February 14, 2014 and not February 17, 2014 as previously
announced.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any of the securities described
herein. Such securities may not be offered or sold in the United
States absent registration under the United States Securities Act
of 1933, as amended (the "U.S. Securities Act")
and applicable state securities laws, or absent an available
exemption from such registration requirements. Any securities sold
pursuant to the Standby Commitment Agreement have not and will not
be registered under the U.S. Securities Act.
About Burcon NutraScience Corporation
Burcon is a leader developing functionally superior plant-based
proteins. Burcon has developed a portfolio of composition,
application, and process patents originating from a core protein
extraction and purification technology. Burcon's CLARISOY™ soy
protein offers clarity and high-quality protein nutrition for low
pH beverage systems; Peazazz® is a uniquely soluble and
clean-tasting pea protein; and Puratein®, Supertein™ and Nutratein®
are canola protein isolates with unique functional and nutritional
attributes. For more information about Burcon, visit
www.burcon.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
"Johann F. Tergesen" Johann F. Tergesen President and Chief
Operating Officer
The TSX has not reviewed and does not accept responsibility for
the adequacy of the content of the information contained herein.
This press release contains forward-looking statements or
forward-looking information. Forward-looking statements or
forward-looking information involve risks, uncertainties and other
factors that could cause actual results, performances, prospects
and opportunities to differ materially from those expressed or
implied by such forward-looking statements. All statements other
than statements of historical fact included in this press release
are forward-looking statements, including, without limitation,
statements with respect to Burcon's intention to complete the
rights offering and the timing and procedures related thereto, and
the listing of the Rights on the TSX and the timing thereof. There
can be no assurance that such statements will prove to be accurate
and actual results and future events could differ materially from
those anticipated in such statements or information. Important
factors that could cause actual results to differ materially from
Burcon's plans and expectations include the actual results of
marketing activities, adverse general economic, market or business
conditions, regulatory changes and other risks and factors detailed
from time to time in the filings made by Burcon with securities
regulators and stock exchanges, including in the section entitled
"Risk Factors" in Burcon's annual information form dated June 25,
2013. Any forward-looking statement or information only speaks as
of the date on which it was made and, except as may be required by
applicable securities laws, Burcon disclaims any intent or
obligation to update any forward-looking statement, whether as a
result of new information, future events or otherwise. Although
Burcon believes that the assumptions inherent in the
forward-looking statements are reasonable, forward-looking
statements are not guarantees of future performance. Accordingly,
undue reliance should not be put on such forward-looking
statements.
CLARISOY is a trademark of Archer Daniels Midland Company.
CONTACT: Media & Industry Contact:
Michael Kirwan
Director, Corporate Development
Burcon NutraScience Corporation
Tel (604) 733-0896, Toll-free (888) 408-7960
mkirwan@burcon.ca
www.burcon.ca
Investor Relations Contact:
Matt Glover or Michael Koehler
Liolios Group Inc.
Tel (949) 574-3860
BUR@liolios.com
Burcon NutraScience (TSX:BU)
Historical Stock Chart
From Jun 2024 to Jul 2024
Burcon NutraScience (TSX:BU)
Historical Stock Chart
From Jul 2023 to Jul 2024